CALCA and osteoporosis: Our data further illuminated the prevailing preferences: calcium and vitamin D emerged as the go-to essential osteoporosis treatments (42.1%), while calcitonin (30.9%) and bisphosphonates (7.1%) dominated the advanced treatment landscape.